Afrezza is a Kit in the Human Prescription Drug category. It is labeled and distributed by Mannkind Corporation. The primary component is .
Product ID | 47918-894_a9010b8f-12ec-4d6a-8a9f-9ad5827d18dd |
NDC | 47918-894 |
Product Type | Human Prescription Drug |
Proprietary Name | Afrezza |
Generic Name | Insulin Human |
Dosage Form | Kit |
Marketing Start Date | 2014-07-11 |
Marketing Category | NDA / NDA |
Application Number | NDA022472 |
Labeler Name | Mannkind Corporation |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2014-07-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022472 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-07-11 |
Marketing End Date | 2019-10-08 |
SPL SET ID: | 29f4637b-e204-425b-b89c-7238008d8c10 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
47918-874 | Afrezza | Insulin Human |
47918-880 | Afrezza | Afrezza |
47918-878 | Afrezza | Afrezza |
47918-894 | Afrezza | Afrezza |
47918-898 | Afrezza | Afrezza |
47918-891 | Afrezza | Afrezza |
47918-902 | Afrezza | Afrezza |
47918-882 | Afrezza | Afrezza |
0002-8215 | Humulin | Insulin human |
0002-8315 | Humulin | Insulin human |
0002-8501 | Humulin | Insulin human |
0002-8715 | Humulin | Insulin human |
0002-8803 | Humulin | Insulin human |
0002-8805 | Humulin | Insulin human |
0002-8824 | Humulin | Insulin human |
0338-0126 | MYXREDLIN | insulin human |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AFREZZA 77808079 3858037 Live/Registered |
MannKind Corporation 2009-08-19 |